MedTrace Pharma

Lyngby, Denmark

MedTrace helps doctors diagnose critically ill patients faster and more accurately.

$19.0M raised

Sep 2023

Venture - Series Unknown

Health Care Health Diagnostics Life Science Medical Device Pharmaceutical

Top Investors

European Innovation CouncilVaekstfondenSwisscanto Private EquityATPSyddansk Innovation

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MedTrace Pharma

How much funding has MedTrace Pharma raised?

MedTrace Pharma has raised $19.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.

Who are MedTrace Pharma's investors?

MedTrace Pharma's investors include European Innovation Council, Vaekstfonden, Swisscanto Private Equity, ATP, Syddansk Innovation.

Where is MedTrace Pharma headquartered?

MedTrace Pharma is headquartered in Lyngby, Denmark.

What does MedTrace Pharma do?

MedTrace helps doctors diagnose critically ill patients faster and more accurately.

What stage is MedTrace Pharma at?

MedTrace Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 21, 2023.

MLA

"MedTrace Pharma — Funding & Investors." VCBacked, September 21, 2023, https://www.vcbacked.co/company/medtrace-pharma. Accessed June 4, 2026.

APA

VCBacked. (2023). MedTrace Pharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/medtrace-pharma

Wikipedia (cite web)

{{cite web |title=MedTrace Pharma — Funding & Investors |url=https://www.vcbacked.co/company/medtrace-pharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 21, 2023.